PRIMARY SCLEROSING CHOLANGITIS IN PATIENTS WITH ULCERATIVE-COLITIS

被引:40
作者
RASMUSSEN, HH
FALLINGBORG, J
MORTENSEN, PB
FREUND, L
TAGEJENSEN, U
KRUSE, V
RASMUSSEN, SN
机构
[1] AALBORG HOSP,DEPT SURG GASTROENTEROL,DK-9000 AALBORG,DENMARK
[2] AALBORG HOSP,DEPT DIAGNOST RADIOL,DK-9000 AALBORG,DENMARK
关键词
ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY; INFLAMMATORY BOWEL DISEASE; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;
D O I
10.3109/00365529209011174
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The prevalence of primary sclerosing cholangitis (PSC) in patients with ulcerative colitis (UC) attending the Depts. of Medical and Surgical Gastroenterology, Aalborg Hospital, during a 12-year period, was determined. All patients with an alkaline phosphatase (ALP) value above the normal range were investigated. Of 305 patients with UC, 24 patients had elevated ALP values, and 11 of these (3.6% of the study population), 4 males and 7 females, were found to have PSC by direct cholangiography. In five patients the disease worsened (two patients died of cholangiocarcinoma), in four it was stationary, and in two patients the disease improved during a mean observation period of 6 years. No differences in location of disease, disease activity, or duration of disease were found between patients with UC and PSC and patients with UC without PSC. The ALP values were raised to a mean of 3.7 times the upper normal limit (observed range, 1.5-5.5 times the upper normal limit). Aspartate aminotransferase was moderately elevated in most patients, but no other abnormal biochemical liver test results were observed at onset. The results of our study indicate that PSC is the major cause of raised ALP values in patients with UC; thus cholangiography should be performed in UC patients with unexplained elevated ALP levels. A prognostic indicator-is needed to predict the individual prognosis and to determine the optimal timing of liver transplantation.
引用
收藏
页码:732 / 736
页数:5
相关论文
共 21 条
[1]  
AADLAND E, 1987, SCAND J GASTROENTERO, V22, P655, DOI 10.3109/00365528709011139
[2]   PRIMARY SCLEROSING CHOLANGITIS WITH NORMAL SERUM ALKALINE-PHOSPHATASE ACTIVITY [J].
BALASUBRAMANIAM, K ;
WIESNER, RH ;
LARUSSO, NF .
GASTROENTEROLOGY, 1988, 95 (05) :1395-1398
[3]  
BINDER V, 1982, GASTROENTEROLOGY, V83, P563
[4]   DISTRIBUTION OF HLA-DR, HLA-DP, HLA-DQ ANTIGENS IN LIVER-TISSUE FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS [J].
BROOME, U ;
GLAUMANN, H ;
HULTCRANTZ, R ;
FORSUM, U .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 (01) :54-58
[5]   SERUM AUTOANTIBODIES, ULCERATIVE-COLITIS AND PRIMARY SCLEROSING CHOLANGITIS [J].
CHAPMAN, RW ;
COTTONE, M ;
SELBY, WS ;
SHEPHERD, HA ;
SHERLOCK, S ;
JEWELL, DP .
GUT, 1986, 27 (01) :86-91
[6]   PRIMARY SCLEROSING CHOLANGITIS - A REVIEW OF ITS CLINICAL-FEATURES, CHOLANGIOGRAPHY, AND HEPATIC HISTOLOGY [J].
CHAPMAN, RWG ;
ARBORGH, BAM ;
RHODES, JM ;
SUMMERFIELD, JA ;
DICK, R ;
SCHEUER, PJ ;
SHERLOCK, S .
GUT, 1980, 21 (10) :870-877
[7]   ASSOCIATION OF PRIMARY SCLEROSING CHOLANGITIS WITH HLA-DRW52A [J].
GRUNNET, N ;
RASMUSSEN, HH ;
TAGEJENSEN, U ;
RASMUSSEN, SN .
TISSUE ANTIGENS, 1991, 38 (03) :133-136
[8]   LONG-TERM PROGNOSIS IN ULCERATIVE-COLITIS - BASED ON RESULTS FROM A REGIONAL PATIENT GROUP FROM THE COUNTY OF COPENHAGEN [J].
HENDRIKSEN, C ;
KREINER, S ;
BINDER, V .
GUT, 1985, 26 (02) :158-163
[9]  
KOLMANNSKOG F, 1981, ACTA RADIOL, V22, P156
[10]  
LUDWIG J, 1981, Hepatology, V1, P632, DOI 10.1002/hep.1840010612